Pathogenic Acanthamoeba castellanii Secretes the Extracellular Aminopeptidase M20/M25/M40 Family Protein to Target Cells for Phagocytosis by Disruption
is free-living protist pathogen capable of causing a blinding keratitis and granulomatous encephalitis. However, the mechanisms of pathogenesis are still not clear. Here, our results show that cells co-cultured with pathogenic would be spherical and floated, even without contacting the protists. The...
Gespeichert in:
Veröffentlicht in: | Molecules (Basel, Switzerland) Switzerland), 2017-12, Vol.22 (12), p.2263 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | is free-living protist pathogen capable of causing a blinding keratitis and granulomatous encephalitis. However, the mechanisms of
pathogenesis are still not clear. Here, our results show that cells co-cultured with pathogenic
would be spherical and floated, even without contacting the protists. Then, the
protists would contact and engulf these cells. In order to clarify the contact-independent pathogenesis mechanism in
, we collected the
-secreted proteins (Asp) to incubate with cells for identifying the extracellular virulent factors and investigating the cytotoxicity process. The Asps of pathogenic
express protease activity to reactive Leu amino acid in ECM and induce cell-losing adhesion ability. The M20/M25/M40 superfamily aminopeptidase protein (ACA1_264610), an aminopeptidase be found in Asp, is upregulated after
and C6 cell co-culturing for 6 h. Pre-treating the Asp with leucine aminopeptidase inhibitor and the specific antibodies of
M20/M25/M40 superfamily aminopeptidase could reduce the cell damage during Asp and cell co-incubation. These results suggest an important functional role of the
secreted extracellular aminopeptidases in the
pathogenesis process. This study provides information regarding clinically pathogenic isolates to target specific molecules and design combined drugs. |
---|---|
ISSN: | 1420-3049 1420-3049 |
DOI: | 10.3390/molecules22122263 |